Invention Grant
- Patent Title: Dihydro-pyrrolopyridinone inhibitors
- Patent Title (中): 二氢吡咯并吡喃酮抑制剂
-
Application No.: US14206028Application Date: 2014-03-12
-
Publication No.: US09321764B2Publication Date: 2016-04-26
- Inventor: Le Wang , John Pratt , Lisa A. Hasvold , Dachun Liu , Yujia Dai , Steven D. Fidanze , James H. Holms , Robert A. Mantei , Keith F. McDaniel , George S. Sheppard , William J. McClellan
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Glen J. Gesicki
- Main IPC: C07D401/04
- IPC: C07D401/04 ; A61K31/4353 ; C07D471/04
Abstract:
The present invention provides for compounds of formula (I) wherein R1, R2, R3, R4, and R5 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).
Public/Granted literature
- US20140275026A1 DIHYDRO-PYRROLOPYRIDINONE INHIBITORS Public/Granted day:2014-09-18
Information query
